0001415889-24-020601.txt : 20240802 0001415889-24-020601.hdr.sgml : 20240802 20240802160259 ACCESSION NUMBER: 0001415889-24-020601 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240801 FILED AS OF DATE: 20240802 DATE AS OF CHANGE: 20240802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heery Christopher CENTRAL INDEX KEY: 0001789632 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41259 FILM NUMBER: 241170869 MAIL ADDRESS: STREET 1: C/O PRECISION BIOSCIENCES, INC. STREET 2: 302 E. PETTIGREW STREET, SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcellx, Inc. CENTRAL INDEX KEY: 0001786205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472855917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 BRIDGE PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 240-327-0603 MAIL ADDRESS: STREET 1: 800 BRIDGE PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 4 1 form4-08022024_080854.xml X0508 4 2024-08-01 0001786205 Arcellx, Inc. ACLX 0001789632 Heery Christopher C/O ARCELLX, INC. 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 false true false false CHIEF MEDICAL OFFICER 1 Common Stock 2024-08-01 4 M 0 9316 6.28 A 18594 D Common Stock 2024-08-01 4 M 0 10684 15 A 29278 D Common Stock 2024-08-01 4 S 0 19268 60.3949 D 10010 D Common Stock 2024-08-01 4 S 0 732 61.128 D 9278 D Stock Option (right to buy) 6.28 2024-08-01 4 M 0 9316 0 D 2031-06-09 Common Stock 9316 54505 D Stock Option (right to buy) 15 2024-08-01 4 M 0 10684 0 D 2032-02-03 Common Stock 10684 179521 D The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 22, 2023. Represents the weighted average share price of an aggregate total of 19,268 shares sold in the price range of $60.00 to $60.99 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 732 shares sold in the price range of $61.00 to $61.81 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Shares issued pursuant to the Issuer's 2017 Equity Incentive Plan (the "2017 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2017 Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 26, 2021. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option will vest each month following the Equity Grant Date on the same day of the month as the Equity Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over four (4) years. "Equity Grant Date" shall mean February 3, 2022. /s/ Michelle Gilson, as Attorney-in-Fact 2024-08-02